Mukaetova-Ladinska_2012_J.Alzheimers.Dis_32_431

Reference

Title : Increase in Platelet Immunoglobulin in Alzheimer's Disease is Normalised Following Cholinesterase Inhibitor Treatment: Preliminary Results - Mukaetova-Ladinska_2012_J.Alzheimers.Dis_32_431
Author(s) : Mukaetova-Ladinska EB , Abdel-All Z , Andrade J , McNally RJ , James PW , Kalaria RN , O'Brien JT
Ref : J Alzheimers Dis , 32 :431 , 2012
Abstract :

We report a 16.5 increase in platelet immunoglobulin Ig content in subjects with Alzheimer's disease AD in relation to cognitively intact individuals p 0.021 whereas the plasma Ig levels were unaltered p 0.428 The upregulation of platelet Ig was not explained by age duration of dementia or degree of cognitive impairment However AD subjects treated with cholinesterase inhibitors n 21 had lower levels of platelet Ig p 0.009 than AD subjects not treated with anti-dementia drugs n 4 and similar to those of control subjects n 24 p 0.069 The anti-dementia treatment did not influence the plasma Ig levels p 0.177 These preliminary findings require further confirmation in studies on larger number of AD subjects with various stages of cognitive impairment and who would be assessed prior to initiation of and during cholinesterase inhibitor treatment.

PubMedSearch : Mukaetova-Ladinska_2012_J.Alzheimers.Dis_32_431
PubMedID: 22810090

Related information

Citations formats

Mukaetova-Ladinska EB, Abdel-All Z, Andrade J, McNally RJ, James PW, Kalaria RN, O'Brien JT (2012)
Increase in Platelet Immunoglobulin in Alzheimer's Disease is Normalised Following Cholinesterase Inhibitor Treatment: Preliminary Results
J Alzheimers Dis 32 :431

Mukaetova-Ladinska EB, Abdel-All Z, Andrade J, McNally RJ, James PW, Kalaria RN, O'Brien JT (2012)
J Alzheimers Dis 32 :431